Skip to main content
. 2020 Oct 27;36(5):1233–1244. doi: 10.1007/s00467-020-04805-y

Fig. 2.

Fig. 2

Patient disposition (stage 1 and stage 2). SFOH, sucroferric oxyhydroxide. Note: More than one reason for study withdrawal may have been given for an individual subject